Article · 2018
Editor
Limin Chen
Lab manager and research scientist, Faculty of Medicine, University of Toronto, Canada
About
As published by the journal they serve.
Limin Chen is a lab manager and research scientist in the Faculty of Medicine at the University of Toronto. He has received a PhD in Molecular Genetics from the University of Toronto in 2005. He has completed his MD in China in 1987 and received a MSc degree in Cancer Biochemistry and Molecular Biology from Sichuan University, China in 1990. He received World Health Organization (WHO) Fellowship and Fellowships from National CIHR Research Training Program in Hepatitis C (NCRTPHepC) and Canadian Institutes of Health Research (CIHR). He is one of the members in Canadian Association for Studying of liver diseases CASL. He received many awards such as the Gold Prize from the 3rd international conference in infectious disease 2009 and Best research Award CASL 2006. He is serving as an editorial board member of many reputed journals and is a reviewer of 4 highprofile journals. He has published more than 20 papers so far with one pioneer paper which has been cited over 110 times.
Research interests
Journals they serve
The seats these journals name them in.
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2018
The Role of Interferon-Inducible Transmembrane Proteins in Virus Infection
Article · 2017
Evasion of Innate Immunity by Dengue Virus Non-Structural Proteins through Interfereing with Type I Interferon Production and Jak/STAT Signaling
Article · 2016
Will Dengue Virus Infection Endanger Blood Safety?
Article · 2016
Pathogen Inactivation Plays an Irreplaceable Role in Safeguarding the Safety of Blood Transfusion
Article · 2016
The role of Interferon Stimulated Gene 56 (ISG56) in Virus-Triggered Signaling and Cellular Antiviral Response
Article · 2015
A Newly Discovered Severe Fever with Thrombocytopenia Syndrome Virus and its Mechanisms in Evading Host Innate Immunity
Article · 2015
B19 Virus Infection and Blood Safety
Article · 2015
A Novel Mechanism of Ubiquitin-Like Protein ISG15 in Regulation of Type I Interferon Signaling: Implication for HCV Persistent Infection
Article · 2014
Is Interferon-Free Treatment for HCV Possible?
Article · 2013
Last Line to Secure Transfusion Safety: Pathogen Inactivation/Reduction Methods in Blood Products-Current Approaches and Perspectives
Article · 2013
Modulating Innate Immune Response to Combat Viral Infections-Use HCV as an Example
Article · 2013
Does the Emerging Bunyavirus that causes Severe Fever with Thrombocytopenia Syndrome Impact the Blood Safety in China?
Article · 2018
Activation of the ubiquitin-like ISG15/USP18 signaling pathway contributes to interferon resistance of HCV and HBV
Article · 2017
Unappreciated role of type-I interferon signaling in HBV and HCV persistent infections and resistance to interferon therapy
Article · 2017
Novel insights into the molecular mechanisms of interferon resistance of hepatitis C and B viruses based on gene expression profiling
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.